Synthesis and anticancer activity of dimeric podophyllotoxin derivatives
Zi, Cheng-Ting1,2,3; Yang, Liu2; Xu, Feng-Qing2; Dong, Fa-Wu2; Yang, Dan2; Li, Yan2; Ding, Zhong-Tao3; Zhou, Jun2; Jiang, Zi-Hua4; Hu, Jiang-Miao2

Background: Podophyllotoxin is a potent cytotoxic agent and serves as a useful lead compound for the development of antitumor drugs. Several podophyllotoxin-derived antitumor agents, including etoposide, are currently in clinical use; however, their therapeutic efficacy is often limited due to side effects and the development of resistance by cancer cells. Previous studies have shown that 4 beta-1,2,3-triazole derivatives of podophyllotoxin exhibit more potent anticancer activity and better binding to topoisomerase-II than etoposide. The effect of dimerization of such derivatives on the anticancer activity has not been studied. Methods: Two moieties of podophyllotoxin were linked at the C-4 position via 1,2,3-triazole rings to give a series of novel dimeric podophyllotoxin derivatives. 4 beta-Azido-substituted podophyllotoxin derivatives (23 and 24) were coupled with various dipropargyl functionalized linkers by utilizing the copper-catalyzed azide-alkyne cycloaddition (CuAAC) reaction to provide dimeric products in very good yield. The in vitro anticancer activity of the synthesized compounds was evaluated by MTT assay against a panel of five human cancer cell lines (HL-60, SMMC-7721, A-549, MCF-7, and SW480). The normal BEAS-2B (lung) cell line was also included for study in order to evaluate the cancer selectivity of the most active compound as compared with normal cells. Results: A group of 16 dimeric podophyllotoxin derivatives with different linkers were synthesized and structurally characterized. Most compounds do not show significant cytotoxicity (IC50 > 40 mM) against all five cancer cell lines. However, one compound (29) which bears a perbutyrylated glucose residue on the glycerol linker is highly potent against all five cancer cell lines tested, with IC50 values ranging from 0.43 to 3.50 mu M. This compound (29) also shows good selectivity towards cancer cell lines as compared with the normal BEAS-2B (lung) cell line, showing selectivity indexes from 4.4 to 35.7. Conclusion: The anticancer activity of dimeric podophyllotoxin derivatives is generally speaking not improved as compared to their monomeric counterparts, and the potency of these dimeric derivatives can be largely affected by the nature of the linker between the two moieties. Among the synthesized derivatives, compound 29 is significantly more cytotoxic and selective towards cancer cells than etoposide and cisplatin, which are currently in clinical use. Compound 29 is a promising anticancer drug and needs further studies.

KeywordPodophyllotoxin Dimeric Podophyllotoxin Derivatives Cuaac Reaction Perbuty-tylated Glucose Antitumor Synthesis
WOS IDWOS:000446694700004
Citation statistics
Cited Times:12[WOS]   [WOS Record]     [Related Records in WOS]
Document Type期刊论文
Corresponding AuthorJiang, Zi-Hua; Hu, Jiang-Miao
Affiliation1.Yunnan Agr Univ, Coll Sci, Key Lab Pu Er Tea Sci, Minist Educ, Kunming 650201, Yunnan, Peoples R China
2.Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Yunnan, Peoples R China
3.Yunnan Univ, Sch Chem Sci & Technol, Minist Educ, Key Lab Med Chem Nat Resource, Kunming 650091, Yunnan, Peoples R China
4.Lakehead Univ, Dept Chem, 955 Oliver Rd, Thunder Bay, ON P7B 5E1, Canada
Recommended Citation
GB/T 7714
Zi, Cheng-Ting,Yang, Liu,Xu, Feng-Qing,et al. Synthesis and anticancer activity of dimeric podophyllotoxin derivatives[J]. DRUG DESIGN DEVELOPMENT AND THERAPY,2018,12:3393-3406.
APA Zi, Cheng-Ting.,Yang, Liu.,Xu, Feng-Qing.,Dong, Fa-Wu.,Yang, Dan.,...&Hu, Jiang-Miao.(2018).Synthesis and anticancer activity of dimeric podophyllotoxin derivatives.DRUG DESIGN DEVELOPMENT AND THERAPY,12,3393-3406.
MLA Zi, Cheng-Ting,et al."Synthesis and anticancer activity of dimeric podophyllotoxin derivatives".DRUG DESIGN DEVELOPMENT AND THERAPY 12(2018):3393-3406.
Files in This Item: Download All
File Name/Size DocType Version Access License
Drug Des. Dev. Ther.(916KB)期刊论文作者接受稿开放获取CC BY-NC-SAView Download
Related Services
Recommend this item
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Zi, Cheng-Ting]'s Articles
[Yang, Liu]'s Articles
[Xu, Feng-Qing]'s Articles
Baidu academic
Similar articles in Baidu academic
[Zi, Cheng-Ting]'s Articles
[Yang, Liu]'s Articles
[Xu, Feng-Qing]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Zi, Cheng-Ting]'s Articles
[Yang, Liu]'s Articles
[Xu, Feng-Qing]'s Articles
Terms of Use
No data!
Social Bookmark/Share
File name: Drug Des. Dev. Ther._2018_Cheng-Ting Zi.pdf
Format: Adobe PDF
All comments (0)
No comment.

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.